Insider Selling: Starling William N JR, Asensus Surgical Inc. [ASXC] Director divested 27,010 shares

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Asensus Surgical Inc. shares valued at $10,804 were sold by Starling William N JR on Jun 13. At $0.40 per share, Starling William N JR sold 27,010 shares. The insider’s holdings dropped to 13,846 shares worth approximately $7615.3 following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Also, Kwo Elizabeth purchased 18,000 shares, netting a total of over 9,558 in proceeds. Following the buying of shares at $0.53 each, the insider now holds 72,201 shares.

Before that, Milne David Bruce had added 225,000 shares to its account. In a trade valued at $139,041, the Director bought Asensus Surgical Inc. shares for $0.62 each. Upon closing the transaction, the insider’s holdings increased to 225,000 shares, worth approximately $0.34 million.

As published in their initiating research note from H.C. Wainwright on May 26, 2021, Asensus Surgical Inc. [ASXC] has been a Buy and the price target has been revised to $4. This represents a 86.25% premium over Thursday’s closing price.

Analyzing ASXC’s Price Performance

On Thursday, Asensus Surgical Inc. [AMEX: ASXC] rose 9.09% to $0.55. The stock’s lowest price that day was $0.52, but it reached a high of $0.55 in the same session. During the last five days, there has been a surge of approximately 22.62%. Over the course of the year, Asensus Surgical Inc. shares have dropped approximately -50.83%. Shares of the company reached a 52-week high of $1.2200 on 01/04/22 and a 52-week low of $0.3500 on 05/12/22. A 50-day SMA is recorded $0.4332, while a 200-day SMA reached $0.8207. Nevertheless, trading volume fell to 1.51 million shares from 0.92 million shares the previous day.

Support And Resistance Levels for Asensus Surgical Inc. (ASXC)

According to the 24-hour chart, there is a support level at 0.5272, which, if violated, would cause prices to drop to 0.5086. In the upper region, resistance lies at 0.5572. The next price resistance is at 0.5686. RSI (Relative Strength Index) is 66.49 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0278, which suggests the price will decrease in the coming days. Percent R is at 3.23%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.

Is Asensus Surgical Inc. subject to short interest?

Stocks of Asensus Surgical Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -9.73 million shares to 9.48 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 19.21 million shares. A decline of -102.64% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.67 of the overall float, the days-to-cover ratio (short ratio) decline to 2.67.

Which companies own the most shares of Asensus Surgical Inc. (ASXC)?

According to BlackRock Fund Advisors filings, the company currently owns 14,237,756 shares, which is about 6.02% of the total ASXC shares outstanding. The investor’s shares have plunged by -292,170 from its previous 13-F filing of 14529926.0 shares. With the completion of the sale transaction, The Vanguard Group, Inc.’s stake is now worth $3,924,762. SSgA Funds Management, Inc. reduced a -44.69% interest valued at $2.8 million while Geode Capital Management LLC sold a -112,273 stake. A total of -114,188 shares of Asensus Surgical Inc. were sold by Northern Trust Investments, Inc. during the quarter, and -191,141 were sold by Citadel Advisors LLC. In its current portfolio, Morgan Stanley Smith Barney LLC holds 1,567,547 shares valued at $0.62 million.

In terms of Asensus Surgical Inc. share price expectations, FactSet research, analysts set an average price target of $4.00 in the next 12 months, up nearly 700.0% from the previous closing price of $0.50. Analysts anticipate Asensus Surgical Inc. stock to reach $4.00 by 2022, with the lowest price target being $4.00. In spite of this, 1 analysts ranked Asensus Surgical Inc. stock as a Buy at the end of 2022.


Please enter your comment!
Please enter your name here